The Guangdong Provincial People’s Hospital (GDPH) and regional Asia-Pacific clinical research organization (CRO) George Clinical have inked a memorandum of understanding (MOU) outlying a collaborative business framework in the area of clinical research in China. The duo seek to pursue training and education in clinical trial services, scientific networking and involvement in trial-related activities, provision of medical monitoring, in-depth feasibility services and investigator networks. China’s clinical research sector is now white hot, and George Clinical seeks to tap in and extend its influence there.
The CRO and Research Center Collaboration: Raising the GcP Bar in China
As China’s clinical research rapidly expands, the level of education, training and “vocational certainty” must evolve. TrialSite News has reported on a number of similar initiatives in China, such as the Eli Lilly and Parexel effort.
The pair here will seek to address several key areas of clinical research operations, including Guangdong Provincial People’s Hospital’s personnel training including investigators, study coordinators, and those relatively new to global clinical trials to build expertise...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).